Skip to main content
Top
Published in: Familial Cancer 4/2015

Open Access 01-12-2015 | Original Article

Prevalence and detection of psychosocial problems in cancer genetic counseling

Authors: W. Eijzenga, E. M. A. Bleiker, D. E. E. Hahn, L. E. Van der Kolk, G. N. Sidharta, N. K. Aaronson

Published in: Familial Cancer | Issue 4/2015

Login to get access

Abstract

Only a minority of individuals who undergo cancer genetic counseling experience heightened levels of psychological distress, but many more experience a range of cancer genetic-specific psychosocial problems. The aim of this study was to estimate the prevalence of such psychosocial problems, and to identify possible demographic and clinical variables associated significantly with them. Consenting individuals scheduled to undergo cancer genetic counseling completed the Psychosocial Aspects of Hereditary Cancer (PAHC) questionnaire, the Hospital Anxiety and Depression Scale (HADS) and the Distress Thermometer (DT) prior to or immediately following their counseling session. More than half of the 137 participants reported problems on three or more domains of the PAHC, most often in the domains ‘living with cancer’ (84 %), ‘family issues’ (46 %), ‘hereditary predisposition’ (45 %), and ‘child-related issues’ (42 %). Correlations between the PAHC, the HADS and the DT were low. Previous contact with a psychosocial worker, and having a personal history of cancer were associated significantly with HADS scores, but explained little variance (9 %). No background variables were associated significantly with the DT. Previous contact with a psychosocial worker, and having children were significantly associated with several PAHC domains, again explaining only a small percentage of the variance (2–14 %). The majority of counselees experience specific cancer genetic counseling-related psychosocial problems. Only a few background variables are associated significantly with distress or psychosocial problems. Thus we recommend using the PAHC or a similar problem-oriented questionnaire routinely in cancer genetic counseling to identify individuals with such problems.
Literature
2.
go back to reference Hamilton JG, Lobel M, Moyer A (2009) Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review. Health Psychol 28(4):510–518PubMedCentralCrossRefPubMed Hamilton JG, Lobel M, Moyer A (2009) Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review. Health Psychol 28(4):510–518PubMedCentralCrossRefPubMed
3.
go back to reference Braithwaite D, Emery J, Walter F, Prevost AT, Sutton S (2006) Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis. FamCancer 5(1):61–75 Braithwaite D, Emery J, Walter F, Prevost AT, Sutton S (2006) Psychological impact of genetic counseling for familial cancer: a systematic review and meta-analysis. FamCancer 5(1):61–75
4.
go back to reference Pasacreta JV (2003) Psychosocial issues associated with genetic testing for breast and ovarian cancer risk: an integrative review. Cancer Invest 21(4):588–623CrossRefPubMed Pasacreta JV (2003) Psychosocial issues associated with genetic testing for breast and ovarian cancer risk: an integrative review. Cancer Invest 21(4):588–623CrossRefPubMed
5.
go back to reference Payne K, Nicholls S, McAllister M, Macleod R, Donnai D, Davies LM (2008) Outcome measurement in clinical genetics services: a systematic review of validated measures. Value Health 11(3):497–508CrossRefPubMed Payne K, Nicholls S, McAllister M, Macleod R, Donnai D, Davies LM (2008) Outcome measurement in clinical genetics services: a systematic review of validated measures. Value Health 11(3):497–508CrossRefPubMed
6.
go back to reference Kasparian NA, Wakefield CE, Meiser B (2007) Assessment of psychosocial outcomes in genetic counseling research: an overview of available measurement scales. J Genet Couns 16(6):693–712CrossRefPubMed Kasparian NA, Wakefield CE, Meiser B (2007) Assessment of psychosocial outcomes in genetic counseling research: an overview of available measurement scales. J Genet Couns 16(6):693–712CrossRefPubMed
7.
go back to reference Vadaparampil ST, Miree CA, Wilson C, Jacobsen PB (2006) Psychosocial and behavioral impact of genetic counseling and testing. Breast Dis 27:97–108PubMed Vadaparampil ST, Miree CA, Wilson C, Jacobsen PB (2006) Psychosocial and behavioral impact of genetic counseling and testing. Breast Dis 27:97–108PubMed
8.
go back to reference Eijzenga W, Hahn DE, Aaronson NK, Kluijt I, Bleiker EMA (2013) Specific psychosocial issues of individuals undergoing genetic counseling for cancer—a literature review. J Genet Couns 23(2):133–146CrossRefPubMed Eijzenga W, Hahn DE, Aaronson NK, Kluijt I, Bleiker EMA (2013) Specific psychosocial issues of individuals undergoing genetic counseling for cancer—a literature review. J Genet Couns 23(2):133–146CrossRefPubMed
9.
go back to reference Vos J, van Asperen CJ, Oosterwijk JC et al (2013) The counselees’ self-reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: not only psychopathology matters. Psychooncology 22(4):902–910CrossRefPubMed Vos J, van Asperen CJ, Oosterwijk JC et al (2013) The counselees’ self-reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: not only psychopathology matters. Psychooncology 22(4):902–910CrossRefPubMed
10.
go back to reference Phelps C, Bennett P, Jones H, Hood K, Brain K, Murray A (2010) The development of a cancer genetic-specific measure of coping: the GRACE. Psychooncology 19(8):847–854CrossRefPubMed Phelps C, Bennett P, Jones H, Hood K, Brain K, Murray A (2010) The development of a cancer genetic-specific measure of coping: the GRACE. Psychooncology 19(8):847–854CrossRefPubMed
11.
go back to reference den Heijer M, Gopie JP, Tibben A (2013) Risk factors for psychological distress in women at risk for hereditary/familial breast cancer: a systematic review. Breast Cancer 2(2):149–162 den Heijer M, Gopie JP, Tibben A (2013) Risk factors for psychological distress in women at risk for hereditary/familial breast cancer: a systematic review. Breast Cancer 2(2):149–162
12.
go back to reference Thewes B, Meiser B, Tucker K, Schnieden V (2003) Screening for psychological distress and vulnerability factors in women at increased risk for breast cancer: a review of the literature. Psychol Health Med 8(3):289–304CrossRef Thewes B, Meiser B, Tucker K, Schnieden V (2003) Screening for psychological distress and vulnerability factors in women at increased risk for breast cancer: a review of the literature. Psychol Health Med 8(3):289–304CrossRef
13.
go back to reference Tuinman MA, Gazendam-Donofrio SM, Hoekstra-Weebers JE (2008) Screening and referral for psychosocial distress in oncologic practice: use of the Distress Thermometer. Cancer 113(4):870–878CrossRefPubMed Tuinman MA, Gazendam-Donofrio SM, Hoekstra-Weebers JE (2008) Screening and referral for psychosocial distress in oncologic practice: use of the Distress Thermometer. Cancer 113(4):870–878CrossRefPubMed
14.
go back to reference van Dooren S, Duivenvoorden H, Passchier J et al (2009) The Distress Thermometer assessed in women at risk of developing hereditary breast cancer. Psycho-Oncology 18(10):1080–1087CrossRefPubMed van Dooren S, Duivenvoorden H, Passchier J et al (2009) The Distress Thermometer assessed in women at risk of developing hereditary breast cancer. Psycho-Oncology 18(10):1080–1087CrossRefPubMed
15.
go back to reference Eijzenga W, Bleiker E, Hahn D et al (2014) Psychosocial Aspects of Hereditary Cancer (PAHC) questionnaire: development and testing of a screening questionnaire for use in clinical cancer genetics. Psycho-Oncology 23:862–869CrossRefPubMed Eijzenga W, Bleiker E, Hahn D et al (2014) Psychosocial Aspects of Hereditary Cancer (PAHC) questionnaire: development and testing of a screening questionnaire for use in clinical cancer genetics. Psycho-Oncology 23:862–869CrossRefPubMed
16.
go back to reference Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM (1997) A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 27(2):363–370CrossRefPubMed Spinhoven P, Ormel J, Sloekers PP, Kempen GI, Speckens AE, Van Hemert AM (1997) A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol Med 27(2):363–370CrossRefPubMed
17.
go back to reference Bennett P, Phelps C, Hilgart J, Hood K, Brain K, Murray A (2012) Concerns and coping during cancer genetic risk assessment. Psychooncology 21(6):611–617CrossRefPubMed Bennett P, Phelps C, Hilgart J, Hood K, Brain K, Murray A (2012) Concerns and coping during cancer genetic risk assessment. Psychooncology 21(6):611–617CrossRefPubMed
18.
go back to reference Riley BD, Culver JO, Skrzynia C et al (2012) Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors. J Genet Couns 21(2):151–161CrossRefPubMed Riley BD, Culver JO, Skrzynia C et al (2012) Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors. J Genet Couns 21(2):151–161CrossRefPubMed
19.
go back to reference Trepanier A, Ahrens M, McKinnon W et al (2004) Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors. JGenetCouns 13(2):83–114 Trepanier A, Ahrens M, McKinnon W et al (2004) Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors. JGenetCouns 13(2):83–114
20.
go back to reference Street RL Jr, Makoul G, Arora NK, Epstein RM (2009) How does communication heal? Pathways linking clinician–patient communication to health outcomes. Patient Educ Couns 74(3):295–301CrossRefPubMed Street RL Jr, Makoul G, Arora NK, Epstein RM (2009) How does communication heal? Pathways linking clinician–patient communication to health outcomes. Patient Educ Couns 74(3):295–301CrossRefPubMed
21.
go back to reference Chen J, Ou L, Hollis SJ (2013) A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting. BMC Health Serv Res 13:211PubMedCentralCrossRefPubMed Chen J, Ou L, Hollis SJ (2013) A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting. BMC Health Serv Res 13:211PubMedCentralCrossRefPubMed
22.
go back to reference Klinkhammer-Schalke M, Koller M, Steinger B et al (2012) Direct improvement of quality of life using a tailored quality of life diagnosis and therapy pathway: randomised trial in 200 women with breast cancer. Br J Cancer 106(5):826–838PubMedCentralCrossRefPubMed Klinkhammer-Schalke M, Koller M, Steinger B et al (2012) Direct improvement of quality of life using a tailored quality of life diagnosis and therapy pathway: randomised trial in 200 women with breast cancer. Br J Cancer 106(5):826–838PubMedCentralCrossRefPubMed
23.
go back to reference Velikova G, Booth L, Smith AB et al (2004) Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J Clin Oncol 22(4):714–724CrossRefPubMed Velikova G, Booth L, Smith AB et al (2004) Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J Clin Oncol 22(4):714–724CrossRefPubMed
24.
go back to reference Detmar SB, Muller MJ, Schornagel JH, Wever LD, Aaronson NK (2002) Health-related quality-of-life assessments and patient–physician communication: a randomized controlled trial. JAMA 288(23):3027–3034CrossRefPubMed Detmar SB, Muller MJ, Schornagel JH, Wever LD, Aaronson NK (2002) Health-related quality-of-life assessments and patient–physician communication: a randomized controlled trial. JAMA 288(23):3027–3034CrossRefPubMed
25.
go back to reference Hilarius DL, Kloeg PH, Gundy CM, Aaronson NK (2008) Use of health-related quality-of-life assessments in daily clinical oncology nursing practice: a community hospital-based intervention study. Cancer 113(3):628–637CrossRefPubMed Hilarius DL, Kloeg PH, Gundy CM, Aaronson NK (2008) Use of health-related quality-of-life assessments in daily clinical oncology nursing practice: a community hospital-based intervention study. Cancer 113(3):628–637CrossRefPubMed
26.
go back to reference Eijzenga W, Aaronson NK, Kluijt I et al (2014) The efficacy of a standardized questionnaire in facilitating personalized communication about problems encountered in cancer genetic counseling: design of a randomized controlled trial. BMC Cancer 14(1):26PubMedCentralCrossRefPubMed Eijzenga W, Aaronson NK, Kluijt I et al (2014) The efficacy of a standardized questionnaire in facilitating personalized communication about problems encountered in cancer genetic counseling: design of a randomized controlled trial. BMC Cancer 14(1):26PubMedCentralCrossRefPubMed
27.
go back to reference Eijzenga W, Aaronson NK, Hahn DEE et al (2014) Effect of routine assessment of specific psychosocial problems on personalized communication, counselors’ awareness, and distress levels in cancer genetic counseling practice: a randomized controlled trial. J Clin Oncol 32:2998–3004CrossRefPubMed Eijzenga W, Aaronson NK, Hahn DEE et al (2014) Effect of routine assessment of specific psychosocial problems on personalized communication, counselors’ awareness, and distress levels in cancer genetic counseling practice: a randomized controlled trial. J Clin Oncol 32:2998–3004CrossRefPubMed
28.
go back to reference Eijzenga W, Bleiker E, Ausems M et al (2014) Routine assessment of psychosocial problems after cancer genetic counseling: results from a randomized controlled trial. Clin Genet 87(5):419–427 Eijzenga W, Bleiker E, Ausems M et al (2014) Routine assessment of psychosocial problems after cancer genetic counseling: results from a randomized controlled trial. Clin Genet 87(5):419–427
Metadata
Title
Prevalence and detection of psychosocial problems in cancer genetic counseling
Authors
W. Eijzenga
E. M. A. Bleiker
D. E. E. Hahn
L. E. Van der Kolk
G. N. Sidharta
N. K. Aaronson
Publication date
01-12-2015
Publisher
Springer Netherlands
Published in
Familial Cancer / Issue 4/2015
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-015-9809-9

Other articles of this Issue 4/2015

Familial Cancer 4/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine